Drug intelligence / Profile preview

cinobufacini

Development stage
Phase 4
Modality
Small Molecules
Administration
Intravenous, Oral
01

Overview

Cinobufacini is a traditional Chinese medicine derived from the skin and parotid glands of the toad Bufo bufo gargarizans Cantor. It is used primarily as an antitumor agent in China and has been formulated as both an injection and capsule. The main active ingredients include bufalin, bufogenin, telocinobufagin, desacetylcinobufagin, arenobufagin (in capsules), and bufothionine (notably in injections). Cinobufacini exerts its anticancer effects through multiple mechanisms including inhibition of cell proliferation, induction of apoptosis and cell cycle arrest in tumor cells, disruption of cancer angiogenesis, reversal of multidrug resistance, immune modulation, and regulation of several signaling pathways such as PI3K-Akt/AKT-mTOR-NF-κB-JAK-STAT-PIN1-YAP/TAZ. It has demonstrated efficacy against various cancers including gastric cancer[1], triple-negative breast cancer[2], osteosarcoma[4], among others. The product is animal-derived (toad secretion) and widely used clinically in China for adjunctive therapy with chemotherapy or as monotherapy for malignant neoplasms.

Brand names
Huachansu
Other names
HuachansuCutis Bufonis extracttoad venom extracttraditional Chinese medicine toad venom injection
02

Targets

PIN1 (Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1)TAZ (Transcriptional coactivator with PDZ-binding motif)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)

Beyond the preview

Go deeper on cinobufacini.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cinobufacini.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call